Search Results - "Carling, Robert W"
-
1
A Second Generation Prostanoid Receptor Antagonist Acting at Multiple Receptor Subtypes
Published in ACS pharmacology & translational science (11-12-2020)“…It has previously been reported that a prototypical compound (AGN 211377), which blocks pro-inflammatory prostanoid receptors (DP1, DP2, EP1, EP4, FP, TP) and…”
Get full text
Journal Article -
2
In vivo studies validating multitargeting of prostanoid receptors for achieving superior anti‐inflammatory effects
Published in The FASEB journal (01-01-2017)“…The purpose of these studies was to test the hypothesis that a selected polypharmacological approach for treating the prostanoid‐mediated component of…”
Get full text
Journal Article -
3
Effect of Plasma Protein Binding on in Vivo Activity and Brain Penetration of Glycine/NMDA Receptor Antagonists
Published in Journal of medicinal chemistry (05-12-1997)“…A major issue in designing drugs as antagonists at the glycine site of the NMDA receptor has been to achieve good in vivo activity. A series of…”
Get full text
Journal Article -
4
Multitargeting of selected prostanoid receptors provides agents with enhanced anti‐inflammatory activity in macrophages
Published in The FASEB journal (01-01-2016)“…ABSTRACT A polypharmacologic approach to prostanoid based anti‐inflammatory therapeutics was undertaken in order to exploit both the anti‐ and proinflammatory…”
Get full text
Journal Article -
5
FAAH-Catalyzed C–C Bond Cleavage of a New Multitarget Analgesic Drug
Published in ACS chemical neuroscience (16-01-2019)“…The discovery of extended catalytic versatilities is of great importance in both the chemistry and biotechnology fields. Fatty acid amide hydrolase (FAAH)…”
Get full text
Journal Article -
6
Cellular basis for bimatoprost effects on human conventional outflow
Published in Investigative ophthalmology & visual science (01-10-2010)“…Bimatoprost is a widely used ocular hypotensive agent to treat glaucoma. It lowers intraocular pressure in humans by increasing both pressure-independent…”
Get full text
Journal Article -
7
4-Amido-2-carboxytetrahydroquinolines. Structure-activity relationships for antagonism at the glycine site of the NMDA receptor
Published in Journal of medicinal chemistry (01-05-1992)“…trans-2-Carboxy-5,7-dichloro-4-amidotetrahydroquinolines, evolved from the lead 5,7-dichlorokynurenic acid, have been synthesized and tested for in vitro…”
Get full text
Journal Article -
8
3-Phenyl-6-(2-pyridyl)methyloxy-1,2,4-triazolo[3,4-a]phthalazines and Analogues: High-Affinity γ-Aminobutyric Acid-A Benzodiazepine Receptor Ligands with α2, α3, and α5-Subtype Binding Selectivity over α1
Published in Journal of medicinal chemistry (25-03-2004)“…Studies with our screening lead 5 and the literature compound 6 led to the identification of 6-benzyloxy-3-(4-methoxy)phenyl-1,2,4-triazolo[3,4-a]phthalazine 8…”
Get full text
Journal Article -
9
An Orally Bioavailable, Functionally Selective Inverse Agonist at the Benzodiazepine Site of GABAA α5 Receptors with Cognition Enhancing Properties
Published in Journal of medicinal chemistry (18-11-2004)“…(3-tert-Butyl-7-(5-methylisoxazol-3-yl)-2-(1-methyl-1H-1,2,4-triazol-5-ylmethoxy)pyrazolo[1,5-d][1,2,4]triazine (13) has been identified as a functionally…”
Get full text
Journal Article -
10
Selective, Orally Active γ-Aminobutyric AcidA α5 Receptor Inverse Agonists as Cognition Enhancers
Published in Journal of medicinal chemistry (22-04-2004)“…Nonselective inverse agonists at the γ-aminobutyric acidA (GABA-A) benzodiazepine binding site have cognition-enhancing effects in animals but are anxiogenic…”
Get full text
Journal Article -
11
Kynurenic acid derivatives. Structure-activity relationships for excitatory amino acid antagonism and identification of potent and selective antagonists at the glycine site on the N-methyl-D-aspartate receptor
Published in Journal of medicinal chemistry (01-04-1991)“…Derivatives of the nonselective excitatory amino acid antagonist kynurenic acid (4-oxo-1,4-dihydroquinoline-2-carboxylic acid, 1) have been synthesized and…”
Get full text
Journal Article -
12
Discovery of Functionally Selective 7,8,9,10-Tetrahydro-7,10-ethano-1,2,4-triazolo[3,4-a]phthalazines as GABAA Receptor Agonists at the α3 Subunit
Published in Journal of medicinal chemistry (10-03-2005)“…We have previously identified the 7,8,9,10-tetrahydro-7,10-ethano-1,2,4-triazolo[3,4-a]phthalazine (1) as a potent partial agonist for the α3 receptor subtype…”
Get full text
Journal Article -
13
Synthesis and Biological Evaluation of 3-Heterocyclyl-7,8,9,10-tetrahydro-(7,10-ethano)-1,2,4-triazolo[3,4-a]phthalazines and Analogues as Subtype-Selective Inverse Agonists for the GABAAα5 Benzodiazepine Binding Site
Published in Journal of medicinal chemistry (01-07-2004)“…The identification of a novel series of 7,8,9,10-tetrahydro-(7,10-ethano)-1,2,4-triazolo[3,4-a]phthalazines as GABAAα5 inverse agonists, which have both…”
Get full text
Journal Article -
14
Discovery of Imidazo[1,2-b][1,2,4]triazines as GABAA α2/3 Subtype Selective Agonists for the Treatment of Anxiety
Published in Journal of medicinal chemistry (23-02-2006)“…The identification of a series of imidazo[1,2-b][1,2,4]triazines with high affinity and functional selectivity for the GABAA α3-containing receptor subtype is…”
Get full text
Journal Article -
15
7-(1,1-Dimethylethyl)-6-(2-ethyl-2H-1,2,4- triazol-3-ylmethoxy)-3-(2-fluorophenyl)- 1,2,4-triazolo[4,3-b]pyridazine: A Functionally Selective γ-Aminobutyric AcidA (GABAA) α2/α3-Subtype Selective Agonist That Exhibits Potent Anxiolytic Activity but Is Not Sedating in Animal Models
Published in Journal of medicinal chemistry (17-11-2005)“…There is increasing evidence that compounds with selectivity for γ-aminobutyric acidA (GABAA) α2- and/or α3-subtypes may retain the desirable anxiolytic…”
Get full text
Journal Article -
16
N',2-Diphenylquinoline-4-carbohydrazide based NK3 receptor antagonists
Published in Bioorganic & medicinal chemistry letters (15-11-2006)“…A new class of potent NK3R antagonists based on the N',2-diphenylquinoline-4-carbohydrazide core is described. In an ex vivo assay in gerbil, the lead compound…”
Get full text
Journal Article -
17
Imidazo[1,2-a]pyrazin-8-ones, imidazo[1,2-d][1,2,4]triazin-8-ones and imidazo[2,1-f][1,2,4]triazin-8-ones as α2/α3 subtype selective GABAA agonists for the treatment of anxiety
Published in Bioorganic & medicinal chemistry letters (15-03-2006)“…Imidazo[1,2-a]pyrazin-8-ones, imidazo[1,2-d][1,2,4]triazin-8-ones and imidazo[2,1-f][1,2,4]triazin-8-ones are high affinity GABAA agonists. Compound 16d has…”
Get full text
Journal Article -
18
N',2-Diphenylquinoline-4-carbohydrazide based NK3 receptor antagonists II
Published in Bioorganic & medicinal chemistry letters (15-11-2006)“…Introduction of selected amine containing side chains into the 3-position of N',2-diphenylquinoline-4-carbohydrazide based NK3 antagonists abolishes unwanted…”
Get full text
Journal Article -
19
2,3,7-Trisubstituted pyrazolo[1,5-d][1,2,4]triazines: Functionally selective GABAA α3-subtype agonists
Published in Bioorganic & medicinal chemistry letters (01-07-2006)“…Novel synthetic routes have been devised for the preparation of previously inaccessible 2,3,7-trisubstituted pyrazolo[1,5-d][1,2,4]triazines 2. These compounds…”
Get full text
Journal Article -
20
2,5-Dihydropyrazolo[4,3-c]pyridin-3-ones: functionally selective benzodiazepine binding site ligands on the GABAA receptor
Published in Bioorganic & medicinal chemistry letters (05-07-2004)“…2,5-Dihydropyrazolo[4,3-c]pyridin-3-ones are GABAA receptor benzodiazepine binding site ligands with functional selectivity for the alpha3 subtype over the…”
Get full text
Journal Article